Patent Yard Sign in
Canadian application, no grantCanada

Synthesis of gatifloxacin

CA 2495271 A1 · Owner: Sterimbaum, Greta · Inventors: Sterimbaum, Greta; Niddam-Hildesheim, Valerie; Pilarski, Gideon

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Provided is a method for making (.plusmn.)-1-Cyclopropyl-6-fluoro-1,4-dihydro- 8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolenecarboxylic acid commonly known as gatifloxacin, in very high purity in a suspension in a , dipolar aprotic solvent.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 14, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 14, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 14, 2003
GrantedNo grant recorded
Term endedAugust 14, 2023
Patent numberCA 2495271 A1
Classification (IPC)C07D401/04 +1 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedAug 14, 2003Term endedAug 14, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.